KR840003247A - 아스코르브산 에테르 및 관련 화합물의 제조방법 - Google Patents
아스코르브산 에테르 및 관련 화합물의 제조방법 Download PDFInfo
- Publication number
- KR840003247A KR840003247A KR1019830000115A KR830000115A KR840003247A KR 840003247 A KR840003247 A KR 840003247A KR 1019830000115 A KR1019830000115 A KR 1019830000115A KR 830000115 A KR830000115 A KR 830000115A KR 840003247 A KR840003247 A KR 840003247A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- ascorbic acid
- general formula
- formula
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33934482A | 1982-01-15 | 1982-01-15 | |
| US339344 | 1989-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR840003247A true KR840003247A (ko) | 1984-08-20 |
Family
ID=23328588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019830000115A Ceased KR840003247A (ko) | 1982-01-15 | 1983-01-14 | 아스코르브산 에테르 및 관련 화합물의 제조방법 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0086554A1 (enExample) |
| JP (1) | JPS58131978A (enExample) |
| KR (1) | KR840003247A (enExample) |
| AU (1) | AU1035183A (enExample) |
| CA (1) | CA1181078A (enExample) |
| DD (1) | DD209455A5 (enExample) |
| DK (1) | DK14283A (enExample) |
| ES (2) | ES8403118A1 (enExample) |
| FI (1) | FI830078A7 (enExample) |
| GB (1) | GB2114571A (enExample) |
| GR (1) | GR77897B (enExample) |
| IL (1) | IL67646A0 (enExample) |
| PL (1) | PL240125A1 (enExample) |
| PT (1) | PT76083B (enExample) |
| RO (1) | RO86439B (enExample) |
| ZA (1) | ZA83173B (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552895A (en) * | 1983-03-14 | 1985-11-12 | Eli Lilly And Company | Furo[3,2-b]furan-2-(3H)-ones |
| JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
| WO1986007592A1 (fr) * | 1985-06-18 | 1986-12-31 | Takeda Chemical Industries, Ltd. | Derives d'acide ascorbique, leur procede de preparation, et preparations les contenant |
| WO1986006720A1 (fr) * | 1985-05-17 | 1986-11-20 | Takeda Chemical Industries, Ltd. | Derives d'acide ascorbique, production desdits derives et preparation pharmaceutique pouvant en resulter |
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法 |
| JPS60139619A (ja) * | 1983-12-27 | 1985-07-24 | Mutsuyuki Kochi | Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤 |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
| ES2099064T3 (es) | 1988-09-01 | 1997-05-16 | Takeda Chemical Industries Ltd | Derivados de fumagillol. |
| WO1991003471A1 (en) * | 1989-09-11 | 1991-03-21 | Nippon Hypox Laboratories Incorporated | Ascorbic acid derivatives |
| US5095126A (en) * | 1990-01-12 | 1992-03-10 | Ohio State University Research Foundation | Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids |
| CA2054743C (en) * | 1990-03-07 | 2001-11-20 | Horst Pauling | Method for preparing derivatives of ascorbic acid |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| JPH0429989A (ja) * | 1990-05-24 | 1992-01-31 | Nisshin Flour Milling Co Ltd | Ｌ―アスコルビン酸誘導体の製造法 |
| GB9026114D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | New compounds |
| GB9201275D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| RU2126398C1 (ru) * | 1993-02-05 | 1999-02-20 | Плива, Фармацеутска, Кемийска, Прехрамбена и Козметичка Индустрия Дионичко Друштво Загреб | Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты |
| US5629327A (en) | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US6114355A (en) * | 1993-03-01 | 2000-09-05 | D'amato; Robert | Methods and compositions for inhibition of angiogenesis |
| US6228879B1 (en) | 1997-10-16 | 2001-05-08 | The Children's Medical Center | Methods and compositions for inhibition of angiogenesis |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| ES2313154T3 (es) | 1996-11-05 | 2009-03-01 | The Children's Medical Center Corporation | Composiciones que comprenden talodimina y dexametasona para el tratamiento de cancer. |
| EP0875246A1 (en) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer |
| NZ506842A (en) * | 1998-03-27 | 2002-06-28 | Lg Chemical Ltd | Antioxidant polyethoxylated ascorbic acid derivatives and process for preparation |
| US6673828B1 (en) | 1998-05-11 | 2004-01-06 | Children's Medical Center Corporation | Analogs of 2-Phthalimidinoglutaric acid |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| AU2001230554A1 (en) * | 2000-02-01 | 2001-08-14 | Mutsuyuki Kochi | Neovascularization inhibitory compositions and method of inhibiting neovascularization |
| AU4258601A (en) * | 2000-03-31 | 2001-10-15 | Angiogene Pharm Ltd | Divided dose therapies with vascular damaging activity |
| WO2003010173A1 (en) * | 2001-07-26 | 2003-02-06 | Tagra Biotechnologies Ltd. | Stabilized derivatives of ascorbic acid -3-phosphate |
| KR100971599B1 (ko) | 2002-05-15 | 2010-07-20 | 비에이취엔 가부시끼가이샤 | 혈관 관련 질환의 예방 또는 치료를 위한 조성물 |
| EP1939192A1 (en) * | 2006-12-28 | 2008-07-02 | Neuropharma S.A. | Cyclopentanone derivatives, method of synthesis and uses thereof |
| FR2955493B1 (fr) * | 2010-01-28 | 2012-02-24 | Oreal | Utilisation de derives d'acide ascorbique en coloration des fibres keratiniques humaines, composition les comprenant, procede de coloration et dispositif |
| JP5602456B2 (ja) * | 2010-02-24 | 2014-10-08 | 日本精化株式会社 | アスコルビン酸誘導体 |
| EP3092220B1 (en) * | 2013-09-25 | 2021-01-20 | University of Florida Research Foundation, Inc. | Vitamin c prodrugs and uses thereof |
| US10105407B2 (en) * | 2015-06-09 | 2018-10-23 | John P. Crow, JR. | Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from myriciaria dubia and methods of synthesis thereof |
| WO2017093354A1 (en) | 2015-11-30 | 2017-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nmdar antagonists for the treatment of diseases associated with angiogenesis |
-
1983
- 1983-01-10 FI FI830078A patent/FI830078A7/fi not_active Application Discontinuation
- 1983-01-10 IL IL67646A patent/IL67646A0/xx unknown
- 1983-01-10 RO RO109663A patent/RO86439B/ro unknown
- 1983-01-11 PT PT76083A patent/PT76083B/pt unknown
- 1983-01-11 CA CA000419220A patent/CA1181078A/en not_active Expired
- 1983-01-11 ZA ZA83173A patent/ZA83173B/xx unknown
- 1983-01-12 DD DD83247195A patent/DD209455A5/de unknown
- 1983-01-12 PL PL24012583A patent/PL240125A1/xx unknown
- 1983-01-13 GR GR70253A patent/GR77897B/el unknown
- 1983-01-13 JP JP58005144A patent/JPS58131978A/ja active Pending
- 1983-01-13 GB GB08300907A patent/GB2114571A/en not_active Withdrawn
- 1983-01-13 ES ES518968A patent/ES8403118A1/es not_active Expired
- 1983-01-13 AU AU10351/83A patent/AU1035183A/en not_active Abandoned
- 1983-01-13 EP EP83300174A patent/EP0086554A1/en not_active Ceased
- 1983-01-14 DK DK14283A patent/DK14283A/da not_active Application Discontinuation
- 1983-01-14 KR KR1019830000115A patent/KR840003247A/ko not_active Ceased
- 1983-08-30 ES ES525239A patent/ES8502698A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| RO86439B (ro) | 1985-03-31 |
| DD209455A5 (de) | 1984-05-09 |
| GB8300907D0 (en) | 1983-02-16 |
| GB2114571A (en) | 1983-08-24 |
| ES525239A0 (es) | 1985-01-16 |
| PL240125A1 (en) | 1984-04-24 |
| PT76083B (en) | 1986-01-09 |
| CA1181078A (en) | 1985-01-15 |
| RO86439A (ro) | 1985-03-15 |
| ES518968A0 (es) | 1984-03-01 |
| DK14283D0 (da) | 1983-01-14 |
| GR77897B (enExample) | 1984-09-25 |
| ES8502698A1 (es) | 1985-01-16 |
| EP0086554A1 (en) | 1983-08-24 |
| AU1035183A (en) | 1983-07-21 |
| FI830078L (fi) | 1983-07-16 |
| DK14283A (da) | 1983-07-16 |
| JPS58131978A (ja) | 1983-08-06 |
| FI830078A0 (fi) | 1983-01-10 |
| ZA83173B (en) | 1984-08-29 |
| IL67646A0 (en) | 1983-05-15 |
| ES8403118A1 (es) | 1984-03-01 |
| FI830078A7 (fi) | 1983-07-16 |
| PT76083A (en) | 1983-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR840003247A (ko) | 아스코르브산 에테르 및 관련 화합물의 제조방법 | |
| KR870001142A (ko) | 페닐 에테르의 제법 | |
| KR850006386A (ko) | 아졸류의 제조방법 | |
| SE8404712D0 (sv) | Azole derivatives, process for their production compositions containing them and their use | |
| KR830001947A (ko) | 화합물의 제조방법 | |
| AU5117890A (en) | Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents | |
| EP0092158A3 (en) | Thiazolidine compound and fungicidal composition containing it | |
| KR900011754A (ko) | (디-3급-부틸히드록시페닐)티오 유도체 | |
| KR840006203A (ko) | N-포르밀 및 n-하이드록시메틸-3-펜옥시-1-아제티딘카복스아미드의 제조방법 | |
| KR910004544A (ko) | 신규 아조페닐 화합물, 이를 함유한 조성물, 이의 제조 방법 및 살균제로서 이들의 이용 | |
| IE832254L (en) | Fungicidal compounds | |
| KR840007578A (ko) | 치환된 니트로 및 시아노구아니딘류의 제조방법 | |
| KR830005104A (ko) | 신규 벤젠아민 및 동물질을 함유하는 조성물의 제조방법 | |
| BR8306629A (pt) | Derivados substituidos de benzilcicloalquenilureia,processo de sua preparacao,composicao para o combate de fungos,emprego,processos para o combate de fungos e para a preparacao de composicoes,benzilcicloaquenilaminas e processo de sua preparacao | |
| KR870003074A (ko) | 피라졸 유도체의 제조방법 | |
| KR840006238A (ko) | 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법 | |
| KR870008849A (ko) | 생식자 박멸효능을 갖는 피라졸류 | |
| JPS559002A (en) | 5-substituted picolinic acid derivative, its preparation and hypotensive agent containing the same | |
| KR830005188A (ko) | 혈당강하성 구아닐 아미딘의 제조방법 | |
| KR840004720A (ko) | 살충제 조성물 및 이의 제조방법 | |
| ES522815A0 (es) | Procedimiento para preparar derivados de (x)-cianidan-3-ol. | |
| KR890003669A (ko) | 제초 활성 페녹시알칸카복실산 유도체 | |
| PT79821B (fr) | Procede de preparation d'aminoethylimidazole comme de la composition pharmaceutique en contenant utilise comme medicament cytoprotecteur | |
| ATE39687T1 (de) | Verfahren zur herstellung von keten-o,n-acetalen. | |
| KR830002718A (ko) | 피라졸 유도체의 제조법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19830114 |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19850727 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19851101 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19850727 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |